Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second-generation antidepressants.

M V Rudorfer, R N Golden, W Z Potter

    The Psychiatric Clinics of North America
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Newly developed antidepressants show promise but haven't fully delivered on improved efficacy or fewer side effects. Their unique mechanisms, however, are valuable for understanding depression and how antidepressants work.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.

    Schizophrenia research·2023
    Same author

    The Role of Metabolites of Antidepressants in the Treatment of Depression.

    CNS drugs·2016
    Same author

    Biomarkers of Brain Structure and Function for Neurodegenerative Disorders: Are They Adequate for Go/No Go Decisions in Drug Development?

    Clinical pharmacology and therapeutics·2015
    Same author

    Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapy.

    International journal of psychiatry in clinical practice·2014
    Same author

    Introduction of a standardized report form improves the quality of mental status examination reports by psychiatry residents.

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
    Same author

    Platelet α2-adrenoreceptors in depression: a critical examination.

    Journal of psychopharmacology (Oxford, England)·2012
    Same journal

    Digital Mental Health: Progress but not Perfection.

    The Psychiatric clinics of North America·2026
    Same journal

    Advances in Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    The Future of Digital Mental Health: A Literature Review.

    The Psychiatric clinics of North America·2026
    Same journal

    Assessment and Treatment of Posttraumatic Stress Disorder via Digital Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    Treatment of Obsessive-Compulsive Disorder via Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    Digital Mental Health Treatments for Depression.

    The Psychiatric clinics of North America·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Psychiatry

    Background:

    • Newly developed antidepressants offer potential clinical advantages over conventional treatments.
    • However, their full potential for improved therapeutic efficacy and reduced adverse effects is not yet realized.
    • These newer agents possess increased biochemical specificity and unique mechanistic profiles.

    Purpose of the Study:

    • To evaluate the clinical advantages of newly developed antidepressant drugs.
    • To assess the realized therapeutic efficacy and adverse effect profiles compared to conventional treatments.
    • To highlight the value of these compounds in researching affective disorder pathophysiology and antidepressant mechanisms.

    Main Methods:

    • Comparative analysis of clinical trial data for novel antidepressants.

    Related Experiment Videos

  • Assessment of biochemical specificity and mechanistic profiles.
  • Review of existing literature on efficacy and adverse effects.

    • Main Results:

    • Newly developed antidepressants offer some clinical advantages to specific patient groups.
    • Promises of significantly improved efficacy and reduced side effects are not consistently met.
    • These drugs exhibit distinct biochemical and mechanistic properties.

    Conclusions:

    • Novel antidepressants hold value for specific patient populations and in research.
    • Further research is needed to fully realize their therapeutic potential and understand their mechanisms.
    • Their biochemical specificity aids in elucidating the pathophysiology of mood disorders.